PERSON DIRECTORY
Paul Matteis
Paul Matteis appears in 30 indexed conversations across Biotech Hangout. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
30 EPISODES1 SHOW
Language
Episode 203 - November 13, 2026
Eric SchmidtYaron WerberPaul MatteisKate Haviland
XBI’s roughly 25% year-to-date gain masks a market still punishing binary risk and financing needs, favoring commercial businesses with pipeline upside.FDA confidence depends on predictable decisions and leadership continuity, while China’s stronger bargaining position has closed earlier licensing arbitrage.PepGen’s near-50% splicing improvement in DM1 is encouraging, but small numbers, potential renal toxicity and pivotal confirmation remain ahead.
